These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6136069)

  • 21. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    Wegener JW; Gath I; Förstermann U; Nawrath H
    Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of guanylate cyclase and the regulatory role of cyclic 3',5'-guanosine monophosphate.
    Severina IS
    Biochem Int; 1988 Aug; 17(2):265-78. PubMed ID: 2903739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B complex vitamins activate rat guanylate cyclase and increase cyclic GMP levels.
    Vesely DL
    Eur J Clin Invest; 1985 Oct; 15(5):258-62. PubMed ID: 2866962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cation-dependent gonadotropin releasing hormone activation of guanylate cyclase.
    Vesely DL
    Mol Cell Biochem; 1985 Mar; 66(2):145-9. PubMed ID: 2858814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II stimulates guanylate cyclase activity in aorta, heart, and kidney.
    Vesely DL
    Am J Physiol; 1981 Apr; 240(4):E391-3. PubMed ID: 6111927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
    Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
    J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
    Severina IS
    Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptides from the N-terminus of the atrial natriuretic factor prohormone enhance guanylate cyclase activity and increase cyclic GMP levels in a wide variety of tissues.
    Vesely DL
    Mol Cell Biochem; 1992 Jan; 109(1):43-50. PubMed ID: 1352037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone and its precursors and metabolites enhance guanylate cyclase activity.
    Vesely DL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3491-4. PubMed ID: 40226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanylate cyclase in neuroblastoma N1E 115 cells: presence of endogenous activator.
    Amano E; Nakane M; Deguchi T
    J Cyclic Nucleotide Res; 1979; 5(2):135-44. PubMed ID: 36417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical evidence of cocarcinogenesis: tumor promoting agent enhances methylnitrosourea activation of rat guanylate cyclase activity.
    Vesely DL
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):329-38. PubMed ID: 37562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guanylate cyclase activity in retina optic nerve and optic chiasm of rats under different illumination conditions.
    Zubin P; Defagot C
    Acta Physiol Pharmacol Ther Latinoam; 1997; 47(3):165-72. PubMed ID: 9339246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscarinic stimulation of cardiac guanylate cyclase.
    George WJ; Ignarro LJ; White LE
    Recent Adv Stud Cardiac Struct Metab; 1975; 7():381-90. PubMed ID: 5759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Guanylate cyclase activity of the rabbit myocardium in normal conditions and in allergic states].
    Miroshnichenko VP; Kriukova GV; Zubovskaia AM; Sharlova IL
    Vopr Med Khim; 1986; 32(2):109-14. PubMed ID: 2871665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ergotamine and dihydroergotamine on 5-hydroxytryptamine-2A receptors in the isolated rat aorta.
    Kalkman HO; Schneider F
    Pharmacology; 1996 Dec; 53(6):351-5. PubMed ID: 9032799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis.
    Banick PD; Chen Q; Xu YA; Thom SR
    J Cell Physiol; 1997 Jul; 172(1):12-24. PubMed ID: 9207921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-genomic effects of tamoxifen on the activation of membrane-bound guanylate cyclase GC-A.
    Chen ZJ; Vetter M; Chang GD; Liu S; Ding Y; Chang CH
    J Pharm Pharmacol; 2003 Nov; 55(11):1539-45. PubMed ID: 14713365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
    Kanto J
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):135-42. PubMed ID: 6133838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor enhances guanylate cyclase activity in vivo and in vitro.
    Scheving LA; Scheving LE; Tsai TH; Vesely DL
    Endocrinology; 1985 Jan; 116(1):332-6. PubMed ID: 2856873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.